Clinical trial Recruiting at 1 site Interventional Ages Any age to 6 Months

Partial versus complete thymus removal during infant heart surgery

Official title: Impact of Thymectomy on Immune Response in Infants 12 Months After Cardiac Surgery: a Single-centre Prospective Study

Run by Nantes University Hospital · NCT07019857 · Data updated 2026-11-12

This will test whether removing only part of the thymus instead of the whole gland during heart surgery helps preserve immune function in infants under 6 months.

Quick facts

Study typeInterventional
AgesAny age to 6 Months
SexAll
Enrollment70 (estimated)
SponsorNantes University Hospital
Academic / other
Locations2 sites (Nantes and 1 other locations)
StatusRecruiting
StartedJuly 25, 2025
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedApril 16, 2026
Trial IDNCT07019857 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants aged 0–6 months born at ≥37 weeks and scheduled for cardiac surgery with cardiopulmonary bypass at Nantes University Hospital, with parental consent, are the primary candidates (with separate control groups for cardiac surgery without thymectomy and non-cardiac surgery).

Probably not a fit

Children older than six months, preterm infants, or those whose anatomy prevents a partial thymectomy are unlikely to benefit from the findings of this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, interventional, single-center study at Nantes University Hospital comparing immune outcomes after partial versus complete thymectomy in infants undergoing cardiac surgery before 6 months of age. Seventy infants are enrolled non-randomly into three groups: complete thymectomy during cardiopulmonary bypass, partial thymectomy during cardiopulmonary bypass, and a control group undergoing cardiac or non-cardiac surgery without thymectomy. Blood samples are collected at the time of surgery and at 12 months postoperatively to measure T-cell counts, maturation markers, and immunological function, and clinical infection rates are tracked. The study aims to see if partial thymectomy better preserves cellular immunity and reduces infection risk compared with total thymus removal.

Why it matters

Potential benefit: If partial thymectomy preserves T-cell development, it could lower infants' infection risk after heart surgery and improve long-term immune health.

How similar studies have gone: Previous observational studies have linked complete infant thymectomy to persistent T-cell changes and higher infection rates, but direct comparisons between partial and complete thymectomy are limited and relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \- Children aged between 0 and 6 months;
* Born at a gestational age \> 37 weeks' gestation;
* With an indication for cardiac surgery under CEC at Nantes University Hospital;
* Cardiopediatric follow-up planned at Nantes University Hospital;
* Written agreement signed by legal guardians to participate in the study.

For the control groups:

* Control group A (cardiac surgery without thymectomy):

  * Children aged between 0 and 6 months of age;
  * Born at a gestational age \> 37 SA;
  * Indicated for thoracotomy cardiac surgery at Nantes University Hospital;
  * Cardiopediatric follow-up planned at Nantes University Hospital;
  * Written agreement signed by legal guardians to participate in the study.
* Control group B (non-cardiac surgery)

  * Children aged between 0 and 6 months;
  * Born at a gestational age \> 37 SA;
  * Indicated for non-cardiac surgery (ENT or visceral surgery at Nantes University Hospital);
  * Planned follow-up surgery at Nantes University Hospital;
  * Written agreement signed by legal guardians to participate in the study.

Exclusion Criteria :

* Gestational age \< 37 SA;
* With a history of cardiac surgery under ECG;
* And/or with heart disease requiring further surgery within 12 months of the 1st surgery (e.g. pulmonary cerclage, systemic pulmonary anastomosis).
* And/or a history of partial or complete thymectomy;
* Receiving long-term immunosuppressive treatment;
* Post-operative follow-up planned in a hospital other than Nantes University Hospital, or moving house planned during the follow-up period;
* parental refusal.

Exclusion Criteria:

* \- Gestational age \< 37 SA;
* With a history of cardiac surgery under ECG;
* And/or with heart disease requiring further surgery within 12 months of the 1st surgery (e.g. pulmonary cerclage, systemic pulmonary anastomosis).
* And/or a history of partial or complete thymectomy;
* Receiving long-term immunosuppressive treatment;
* Post-operative follow-up planned in a hospital other than Nantes University Hospital, or moving house planned during the follow-up period;
* parental refusal.

Where it's running

  • Chu de Nantes
    Nantes, France
    Recruiting
  • CHU de Nantes
    Nantes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.